FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Tolmetin sodium submitted by Atland Pharmaceuticals, LLC under ANDA073393.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Tolmetin sodium (Tolmetin sodium)

Snippet

SUPPL AP for TOLMETIN SODIUM (TOLMETIN SODIUM)